Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dysplastic nevus syndrome].

G Niebauer, E M Kokoschka

    Wiener Klinische Wochenschrift
    |October 24, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Dysplastic nevus syndrome (DNS) is a genetic precursor to melanoma, observed in 3% of melanoma patients. Research indicates early signs of malignant transformation in dysplastic nevi, suggesting a need for further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Computed tomographic study of the optimal safe implantation corridors in feline thoraco-lumbar vertebrae.

    Veterinary and comparative orthopaedics and traumatology : V.C.O.T·2013
    Same author

    Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer.

    Melanoma research·1999
    Same author

    [Thymopentin in alopecia areata].

    Acta medica Austriaca·1998
    Same author

    Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial.

    Archives of dermatology·1998
    Same author

    Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.

    International journal of cancer·1997
    Same author

    [The bacteria are returning].

    Krankenpflege Journal·1996
    Same journal

    [Vaccination of immunocompromised individuals: Expert opinion - update 2026].

    Wiener klinische Wochenschrift·2026
    Same journal

    Systematic review of clinical evidence for Kneipp medicine.

    Wiener klinische Wochenschrift·2026
    Same journal

    Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

    Wiener klinische Wochenschrift·2026
    Same journal

    Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

    Wiener klinische Wochenschrift·2026
    Same journal

    Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

    Wiener klinische Wochenschrift·2026
    Same journal

    MUW researcher of the month: Dr. Moritz Schaefer.

    Wiener klinische Wochenschrift·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Genetics
    • Oncology

    Context:

    • Dysplastic nevus (DN) described by Clark in 1976.
    • Dysplastic nevus syndrome (DNS) characterized by familial occurrence.
    • Limited prevalence of DNS (3%) among melanoma patients.

    Purpose:

    • To investigate the genetic basis and biological activity of dysplastic nevi.
    • To evaluate the potential of dysplastic nevi as melanoma precursors.
    • To analyze signs of malignant transformation in dysplastic nevi.

    Summary:

    • Dysplastic nevus syndrome (DNS) affects a small percentage of melanoma patients but shows direct genetic penetration.
    • Cell culture and T-lymphocyte analyses reveal incipient malignant transformation in dysplastic nevi.
    • No HLA phenotype preference was observed in DNS patients.

    Related Experiment Videos

    Impact:

    • Highlights the significance of dysplastic nevi as melanoma precursors.
    • Suggests potential for early detection and intervention strategies for melanoma.
    • Provides insights into the biological mechanisms underlying melanoma development.